Academician , Chief Architect of Discipline and Endocrine Tumor Research
Affiliated HospitalRuijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine
→
Research areas: Clinical diagnosis and treatment of hereditary endocrine and metabolic diseases, adrenal diseases and diabetes; pathogenesis and pathogenic genes of endocrine tumors.
Cutting-edge technologies: Discovering the pathogenesis and pathogenic genes of multiple endocrine neoplasia type 1, islet cell tumors, and adrenal Cushing's syndrome, and standardizing and optimizing treatment protocols. Dedicated to creating a biobank research model for large-scale cohort studies.
Specializes in treating: endocrine tumors, adrenal gland diseases, diabetes, and hereditary endocrine and metabolic disorders.
Academic Highlights and Core Values: Academician of the Chinese Academy of Engineering, Vice President of Ruijin Hospital, Director of the Shanghai Institute of Endocrinology and Metabolic Diseases, and Director of the National Clinical Research Center for Metabolic Diseases. He has presided over more than 20 projects, including the National Science and Technology Support Program, the National Natural Science Foundation of China Innovation Research Group, and the 973 Program. He is the first Chinese expert to serve on the Executive Committee of the International Society of Endocrinology and founded the first SCI journal in this field in China, the Journal of Diabetes.